References
- Ahmad K, Hassan Baig M, Mushtaq G, et al. Commonalities in biological pathways, genetics, and cellular mechanism between Alzheimer Disease and other neurodegenerative diseases: an in silico-updated overview. Curr Alzheimer Res. 2017;14(11):1190–1197. 1
- Guo F, Liu X, Cai H, et al. Autophagy in neurodegenerative diseases: pathogenesis and therapy. Brain Pathol. 2018;28(1):3–13.
- Kesidou E, Lagoudaki R, Touloumi O, et al. Autophagy and neurodegenerative disorders. Neural Regen Res. 2013;8(24):2275–2283.
- Shimizu S, Fujikake N, Shin M. Association between autophagy and neurodegenerative diseases. Front Neurosci. 2018;12:255.
- Wong E, Cuervo AM. Autophagy gone awry in neurodegenerative diseases. Nat Neurosci. 2010;13(7):805–811. Jul
- Glick D, Barth S, Macleod KF. Autophagy: cellular and molecular mechanisms. J Pathol. 2010;221(1):3–12.
- Clark SL. Cellular differentiation in the kidneys of newborn mice studies with the electron microscope. J Biophys Biochem Cytol. 1957;3(3):349–362.
- Ashford TP, Porter KR. Cytoplasmic components in hepatic cell lysosomes. J Cell Biol. 1962;12(1):198–202.
- Novikoff AB, Essner E. Cytolysomes and mitochondrial degeneration. J Cell Biol. 1962;15(1):140–146. PMC][https://doi.org/10.1083/jcb.15.1.140] [13939127]
- Hara T, Nakamura K, Matsui M, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 2006;441(7095):885–889.
- Komatsu M, Waguri S, Chiba T, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 2006;441(7095):880–884. PMC][https://doi.org/10.1038/nature04723] [16625205]
- Kroemer G, Mariño G, Levine B. Autophagy and the integrated stress response. Mol Cell. 2010;40(2):280–293. doi:https://doi.org/10.1016/j.molcel.2010.09.023">10.1016/j.molcel.2010.09.023] 20965422]
- Forman MS, Trojanowski JQ, Lee VM. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med. 2004;10(10):1055–1063.
- Tsukada M, Ohsumi Y. Isolation and characterization of autophagy‐defective mutants of Saccharomyces cerevisiae. FEBS Lett. 1993;333(1-2):169–174.
- Ciechanover A, Finley D, Varshavsky A. The ubiquitin-mediated proteolytic pathway and mechanisms of energy-dependent intracellular protein degradation. J Cell Biochem. 1984;24(1):27–53.
- Gropper R, Brandt RA, Elias S, et al. The ubiquitin-activating enzyme, E1, is required for stress-induced lysosomal degradation of cellular proteins. J Biol Chem. 1991;266(6):3602–3610.
- Hershko A, Heller H, Elias S, et al. Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown. J Biol Chem. 1983;258(13):8206–8214. PMC][6305978]
- Schulman BA, Harper JW. Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways. Nat Rev Mol Cell Biol. 2009;10(5):319–331.
- Stephen AG, Trausch-Azar JS, Ciechanover A, et al. The ubiquitin-activating enzyme E1 is phosphorylated and localized to the nucleus in a cell cycle-dependent manner. J Biol Chem. 1996;271(26):15608–15614. doi:https://doi.org/10.1074/jbc.271.26.15608] [8663123]
- Nassif ND, Cambray SE, Kraut DA. Slipping up: partial substrate degradation by ATP-dependent proteases. IUBMB Life. 2014;66(5):309–317. doi:https://doi.org/10.1002/iub.1271">10.1002/iub.1271] [24823973]
- Wang J, Maldonado MA. The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases. Cell Mol Immunol. 2006;3(4):255–261.
- Jackson MP, Hewitt EW. Cellular proteostasis: degradation of misfolded proteins by lysosomes. Essays Biochem. 2016;60(2):173–180. doi:https://doi.org/10.1042/EBC20160005] [27744333]
- Kocaturk NM, Gozuacik D. Crosstalk Between Mammalian Autophagy and the Ubiquitin-Proteasome System. Front Cell Dev Biol. 2018;6:128.
- Wu H, Niu H, Wu C, et al. The autophagy-lysosomal system in subarachnoid haemorrhage. J Cell Mol Med. 2016;20(9):1770–1778.
- Kim YC, Guan KL. mTOR: a pharmacologic target for autophagy regulation. J Clin Invest. 2015;125(1):25–32.
- Paquette M, El-Houjeiri L, Pause A. mTOR pathways in cancer and autophagy. Cancers. 2018;10(1):18.
- Füllgrabe J, Ghislat G, Cho DH, et al. Transcriptional regulation of mammalian autophagy at a glance. J Cell Sci. 2016;129(16):3059–3066.
- Rabanal-Ruiz Y, Otten EG, Korolchuk VI. mTORC1 as the main gateway to autophagy. Essays Biochem. 2017;61(6):565–584. doi:https://doi.org/10.1042/EBC20170027] [29233869]
- Bala S, Szabo G. TFEB, a master regulator of lysosome biogenesis and autophagy, is a new player in alcoholic liver disease. Dig Med Res. 2018;1:16–16. doi:https://doi.org/10.21037/dmr.2018.09.03
- Martina JA, Chen Y, Gucek M, et al. MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy. 2012;8(6):903–914. doi:https://doi.org/10.4161/auto.19653">10.4161/auto.19653] [22576015]
- Tong Y, Song F. Intracellular calcium signaling regulates autophagy via calcineurin-mediated TFEB dephosphorylation. Autophagy. 2015;11(7):1192–1195. Jul 3
- Napolitano G, Ballabio A. TFEB at a glance. J Cell Sci. 2016;129(13):2475–2481. doi:https://doi.org/10.1242/jcs.146365] [27252382]
- Sardiello M. Transcription factor EB: from master coordinator of lysosomal pathways to candidate therapeutic target in degenerative storage diseases. Ann N Y Acad Sci. 2016;1371(1):3–14.
- Zhao E, Czaja MJ. Transcription factor EB: a central regulator of both the autophagosome and lysosome. Hepatology. 2012;55(5):1632–1634.
- Hosokawa N, Hara T, Kaizuka T, et al. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell. 2009;20(7):1981–1991.
- Kim DH, Sarbassov DD, Ali SM, et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell. 2002;110(2):163–175.
- Laplante M, Sabatini DM. mTOR signaling at a glance. J Cell Sci. 2009;122(Pt 20):3589–3594.
- Lipton JO, Sahin M. The neurology of mTOR. Neuron. 2014;84(2):275–291. doi:https://doi.org/10.1016/j.neuron.2014.09.034] [25374355]
- Cargnello M, Tcherkezian J, Roux PP. The expanding role of mTOR in cancer cell growth and proliferation. Mutagenesis. 2015;30(2):169–176. doi:https://doi.org/10.1093/mutage/geu045] [25688110]
- Fingar DC, Richardson CJ, Tee AR, et al. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol Cell Biol. 2004;24(1):200–216. doi:https://doi.org/10.1128/mcb.24.1.200-216.2004] [14673156]
- Hung CM, Garcia-Haro L, Sparks CA, et al. mTOR-dependent cell survival mechanisms. Cold Spring Harbor Perspect Biol. 2012;4(12):a008771–a008771. doi:https://doi.org/10.1101/cshperspect.a008771
- Kim J, Guan KL. mTOR as a central hub of nutrient signalling and cell growth. Nat Cell Biol. 2019;21(1):63–71.
- Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168(6):960–976. doi:https://doi.org/10.1016/j.cell.2017.02.004] [28283069]
- Hall MN. mTOR-what does it do? Transplant Proc. 2008;40(10 Suppl):S5–S8.
- Jewell JL, Guan KL. Nutrient signaling to mTOR and cell growth. Trends Biochem Sci. 2013;38(5):233–242.
- Kim SG, Buel GR, Blenis J. Nutrient regulation of the mTOR complex 1 signaling pathway. Mol Cells. 2013;35(6):463–473. doi:https://doi.org/10.1007/s10059-013-0138-2] [23694989]
- Pereira L, Girardi JP, Bakovic M. Forms, crosstalks, and the role of phospholipid biosynthesis in autophagy. Int J Cell Biol. 2012;2012:931956.
- Groenewoud MJ, Zwartkruis FJ. Rheb and Rags come together at the lysosome to activate mTORC1. Biochem Soc Trans. 2013;41(4):951–955.
- Sato T, Umetsu A, Tamanoi F. Characterization of the Rheb-mTOR signaling pathway in mammalian cells: constitutive active mutants of Rheb and mTOR . Meth Enzymol. 2008;438:307–320.
- Inoki K, Li Y, Xu T, Guan KL. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 2003;17(15):1829–1834.
- Inoki K, Li Y, Zhu T, Wu J, et al. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol. 2002;4(9):648–657.
- Li Y, Corradetti MN, Inoki K, et al. TSC2: filling the GAP in the mTOR signaling pathway. Trends Biochem Sci. 2004;29(1):32–38.
- Ma L, Chen Z, Erdjument-Bromage H, et al. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell. 2005;121(2):179–193.
- Huang J, Manning BD. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J. 2008;412(2):179–190. doi:https://doi.org/10.1042/BJ20080281] [18466115]
- Cao Y, Kamioka Y, Yokoi N, et al. Interaction of FoxO1 and TSC2 induces insulin resistance through activation of mTOR/p70S6K pathway. J Biol Chem. 2006;281(52):40242–40251. doi:https://doi.org/10.1074/jbc.M608116200
- Huang J, Dibble CC, Matsuzaki M, et al. The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Mol Cell Biol. 2008;28(12):4104–4115.
- Völkers M, Sussman M. mTOR/PRAS40 interaction: hypertrophy or proliferation. Cell Cycle. 2013;12(23):3579–3580. doi:https://doi.org/10.4161/cc.26822]
- Wang L, Harris TE, Roth RA, et al. PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding. J Biol Chem. 2007;282(27):20036–20044.
- Dan HC, Sun M, Yang L, et al. Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. J Biol Chem. 2002;277(38):35364–35370.
- Dibble CC, Cantley LC. Regulation of mTORC1 by PI3K signaling. Trends Cell Biol. 2015;25(9):545–555.doi:https://doi.org/10.1016/j.tcb.2015.06.002] [26159692">26159692]
- Lv D, Guo L, Zhang T, et al. PRAS40 signaling in tumor. Oncotarget. 2017;8(40):69076–69085.
- Wang H, Zhang Q, Wen Q, et al. Proline-rich Akt substrate of 40kDa (PRAS40): a novel downstream target of PI3k/Akt signaling pathway . Cell Signal. 2012;24(1):17–24.
- Barialai L. P01. 04 AMPK activation and glycolysis inhibition protect neural cells from glucose and oxygen restriction. Neuro-Oncology. 2017;19(suppl_3):iii23–iii23.
- Herrero‐Martín G, Høyer‐Hansen M, García‐García C, et al. TAK1 activates AMPK‐dependent cytoprotective autophagy in TRAIL‐treated epithelial cells. Embo J. 2009;28(6):677–685.
- Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell. 2008;30(2):214–226.
- Hindupur SK, González A, Hall MN. The opposing actions of target of rapamycin and AMP-activated protein kinase in cell growth control. Cold Spring Harb Perspect Biol. 2015;7(8):a019141.
- Chang C, Su H, Zhang D, et al. AMPK-dependent phosphorylation of GAPDH triggers Sirt1 activation and is necessary for autophagy upon glucose starvation. Mol Cell. 2015;60(6):930–940.
- Lee MN, Ha SH, Kim J, et al. Glycolytic flux signals to mTOR through glyceraldehyde-3-phosphate dehydrogenase-mediated regulation of Rheb. Mol Cell Biol. 2009;29(14):3991–4001. doi:https://doi.org/10.1128/MCB.00165-09] [19451232]
- Efeyan A, Zoncu R, Sabatini DM. Amino acids and mTORC1: from lysosomes to disease. Trends Mol Med. 2012;18(9):524–533.
- Demetriades C, Doumpas N, Teleman AA. Regulation of TORC1 in response to amino acid starvation via lysosomal recruitment of TSC2. Cell. 2014;156(4):786–799.
- Potter CJ, Pedraza LG, Xu T. Akt regulates growth by directly phosphorylating Tsc2. Nat Cell Biol. 2002;4(9):658–665.
- Roux PP, Ballif BA, Anjum R, et al. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc Natl Acad Sci USA. 2004;101(37):13489–13494. doi:https://doi.org/10.1073/pnas.0405659101] [15342917]
- Semenza GL. Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning. Biochim Biophys Acta. 2011;1813(7):1263–1268. doi:https://doi.org/10.1016/j.bbamcr.2010.08.006] [20732359]
- Zhang L, Li L, Liu H, et al. HIF-1alpha activation by a redox-sensitive pathway mediates cyanide-induced BNIP3 upregulation and mitochondrial-dependent cell death. Free Radic Biol Med. 2007;43(1):117–127. doi:https://doi.org/10.1016/j.freeradbiomed.2007.04.005
- Armijo ME, Campos T, Fuentes‐Villalobos F, et al. Rheb signaling and tumorigenesis: mTORC1 and new horizons. Int J Cancer. 2016;138(8):1815–1823.
- Li L, Zhang X, Le W. Autophagy dysfunction in Alzheimer's disease. Neurodegener Dis. 2010;7(4):265–271.
- Brugarolas J, Lei K, Hurley RL, et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev. 2004;18(23):2893–2904. doi:https://doi.org/10.1101/gad.1256804] [15545625]
- Kim J, Yang G, Kim Y, et al. AMPK activators: mechanisms of action and physiological activities. Exp Mol Med. 2016;48(4):e224.
- Mihaylova MM, Shaw RJ. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol. 2011;13(9):1016–1023.
- Shang L, Chen S, Du F, et al. Nutrient starvation elicits an acute autophagic response mediated by Ulk1 dephosphorylation and its subsequent dissociation from AMPK. Proc Natl Acad Sci USA. 2011;108(12):4788–4793.
- Ganley IG. Autophagosome maturation and lysosomal fusion. Essays Biochem. 2013;55:65–78. doi:https://doi.org/10.1042/bse0550065] [24070472]
- Alers S, Löffler AS, Paasch F, et al. Atg13 and FIP200 act independently of Ulk1 and Ulk2 in autophagy induction. Autophagy. 2011;7(12):1424–1433.
- Funderburk SF, Wang QJ, Yue Z. The Beclin 1-VPS34 complex-at the crossroads of autophagy and beyond. Trends Cell Biol. 2010;20(6):355–362.
- Kihara A, Noda T, Ishihara N, et al. Two distinct Vps34 phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidase Y sorting in Saccharomyces cerevisiae. J Cell Biol. 2001;152(3):519–530. doi:https://doi.org/10.1083/jcb.152.3.519] [11157979]
- Klionsky DJ. The molecular machinery of autophagy: unanswered questions. J Cell Sci. 2005;118(Pt 1):7–18. doi:https://doi.org/10.1242/jcs.01620] [15615779]
- Zhou X, Wang F. Effects of neuronal PIK3C3/Vps34 deletion on autophagy and beyond. Autophagy. 2010;6(6):798–799.
- Burman C, Ktistakis NT. Regulation of autophagy by phosphatidylinositol 3-phosphate. FEBS Lett. 2010;584(7):1302–1312.
- Jaber N, Dou Z, Chen JS, et al. Class III PI3K Vps34 plays an essential role in autophagy and in heart and liver function. Proc Natl Acad Sci Usa. 2012;109(6):2003–2008.
- Stjepanovic G, Baskaran S, Lin MG, et al. Vps34 kinase domain dynamics regulate the autophagic PI 3-kinase complex. Mol Cell. 2017;67(3):528–534. doi:https://doi.org/10.1016/j.molcel.2017.07.003] [28757208]
- Obara K, Noda T, Niimi K, et al. Transport of phosphatidylinositol 3-phosphate into the vacuole via autophagic membranes in Saccharomyces cerevisiae . Genes Cells. 2008;13(6):537–547.doi:https://doi.org/10.1111/j.1365-2443.2008.01188.x] [18533003]
- Obara K, Ohsumi Y. Dynamics and function of PtdIns(3)P in autophagy. Autophagy. 2008;4(7):952–954.
- Russell RC, Tian Y, Yuan H, Park HW, et al. ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat Cell Biol. 2013;15(7):741–750.
- Yan Y, Flinn RJ, Wu H, et al. hVps15, but not Ca2+/CaM, is required for the activity and regulation of hVps34 in mammalian cells. Biochem J. 2009;417(3):747–755. doi:https://doi.org/10.1042/BJ20081865] [18957027]
- Dunn WA. Studies on the mechanisms of autophagy: formation of the autophagic vacuole. J Cell Biol. 1990;110(6):1923–1933. doi:https://doi.org/10.1083/jcb.110.6.1923] [2351689]
- Huotari J, Helenius A. Endosome maturation. Embo J. 2011;30(17):3481–3500. doi:https://doi.org/10.1038/emboj.2011.286] [21878991]
- Reggiori F, Ungermann C. Autophagosome maturation and fusion. J Mol Biol. 2017;429(4):486–496. Feb 17
- He C, Levine B. The beclin 1 interactome. Curr Opin Cell Biol. 2010;22(2):140–149.
- Kang R, Zeh HJ, Lotze MT, et al. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 2011;18(4):571–580. doi:https://doi.org/10.1038/cdd.2010.191] [21311563]
- Maiuri MC, Criollo A, Tasdemir E, et al. BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L) . Autophagy. 2007;3(4):374–376. ][https://doi.org/10.4161/auto.4237
- Itakura E, Kishi C, Inoue K, et al. Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Mol Biol Cell. 2008;19(12):5360–5372. doi:https://doi.org/10.1091/mbc.e08-01-0080] [18843052]
- Lystad AH, Simonsen A. Mechanisms and pathophysiological roles of the ATG8 conjugation machinery. Cells. 2019;8(9):973.
- Abounit K, Scarabelli TM, McCauley RB. Autophagy in mammalian cells. World J Biol Chem. 2012;3(1):1–6.
- Bernard A, Klionsky DJ. Autophagosome formation: tracing the source. Dev Cell. 2013;25(2):116–117.
- Rubinsztein DC, Shpilka T, Elazar Z. Mechanisms of autophagosome biogenesis. Curr Biol. 2012;22(1):R29–34.
- Donaldson KM, Li W, Ching KA, et al. Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates. Proc Natl Acad Sci Usa. 2003;100(15):8892–8897.
- Shaid S, Brandts CH, Serve H, et al. Ubiquitination and selective autophagy. Cell Death Differ. 2013;20(1):21–30.
- Zaffagnini G, Martens S. Mechanisms of selective autophagy. J Mol Biol. 2016;428(9 Pt A):1714–1724.
- Pohl C, Jentsch S. Midbody ring disposal by autophagy is a post-abscission event of cytokinesis. Nat Cell Biol. 2009;11(1):65–70.
- Shvets E, Fass E, Scherz-Shouval R, et al. The N-terminus and Phe52 residue of LC3 recruit p62/SQSTM1 into autophagosomes. J Cell Sci. 2008;121(Pt 16):2685–2695. doi:https://doi.org/10.1242/jcs.026005] [18653543]
- Vadlamudi RK, Joung I, Strominger JL, et al. p62, a phosphotyrosine-independent ligand of the SH2 domain of p56lck, belongs to a new class of ubiquitin-binding proteins. J Biol Chem. 1996;271(34):20235–20237.
- Matsumoto G, Wada K, Okuno M, et al. Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. Mol Cell. 2011;44(2):279–289. doi:https://doi.org/10.1016/j.molcel.2011.07.039] [22017874]
- Kirkin V, Lamark T, Johansen T, et al. NBR1 cooperates with p62 in selective autophagy of ubiquitinated targets . Autophagy. 2009;5(5):732–733.
- Lamark T, Kirkin V, Dikic I, et al. NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets. Cell Cycle. 2009;8(13):1986–1990.
- Korolchuk VI, Rubinsztein DC. Regulation of autophagy by lysosomal positioning. Autophagy. 2011;7(8):927–928.
- Pu J, Guardia CM, Keren-Kaplan T, et al. Mechanisms and functions of lysosome positioning. J Cell Sci. 2016;129(23):4329–4339.
- Wang T, Ming Z, Xiaochun W, et al. Rab7: role of its protein interaction cascades in endo-lysosomal traffic. Cell Signal. 2011;23(3):516–521. doi:https://doi.org/10.1016/j.cellsig.2010.09.012] [20851765]
- Nakamura S, Yoshimori T. New insights into autophagosome-lysosome fusion. J Cell Sci. 2017;130(7):1209–1216. doi:https://doi.org/10.1242/jcs.196352] [28302910]
- Kimura S, Noda T, Yoshimori T. Dynein-dependent movement of autophagosomes mediates efficient encounters with lysosomes. Cell Struct Funct. 2008;33(1):109–122.
- Ao X, Zou L, Wu Y. Regulation of autophagy by the Rab GTPase network. Cell Death Differ. 2014;21(3):348–358.
- Jäger S, Bucci C, Tanida I, et al. Role for Rab7 in maturation of late autophagic vacuoles. J Cell Sci. 2004;117(Pt 20):4837–4848. doi:https://doi.org/10.1242/jcs.01370] [15340014]
- Guerra F, Bucci C. Multiple roles of the small GTPase Rab7. Cells. 2016;5(3):34.
- Hutagalung AH, Novick PJ. Role of Rab GTPases in membrane traffic and cell physiology. Physiol Rev. 2011;91(1):119–149.
- Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol. 2009;10(8):513–525.
- Jiang P, Nishimura T, Sakamaki Y, et al. The HOPS complex mediates autophagosome-lysosome fusion through interaction with syntaxin 17. Mol Biol Cell. 2014;25(8):1327–1337.
- Takáts S, Glatz G, Szenci G, et al. Non-canonical role of the SNARE protein Ykt6 in autophagosome-lysosome fusion. PLoS Genet. 2018;14(4):e1007359.
- Takáts S, Nagy P, Varga Á, et al. Autophagosomal Syntaxin17-dependent lysosomal degradation maintains neuronal function in Drosophila. J Cell Biol. 2013;201(4):531–539.
- Takáts S, Pircs K, Nagy P, et al. Interaction of the HOPS complex with Syntaxin 17 mediates autophagosome clearance in Drosophila. Mol Biol Cell. 2014;25(8):1338–1354.
- Itakura E, Kishi-Itakura C, Mizushima N. The hairpin-type tail-anchored SNARE syntaxin 17 targets to autophagosomes for fusion with endosomes/lysosomes. Cell. 2012;151(6):1256–1269.
- Kleine Balderhaar HJ, Ungermann C. CORVET and HOPS tethering complexes - coordinators of endosome and lysosome fusion. J Cell Sci. 2013;126(Pt 6):1307–1316.
- Solinger JA, Spang A. Tethering complexes in the endocytic pathway: CORVET and HOPS. Febs J. 2013;280(12):2743–2757.
- van der Kant R, Jonker CT, Wijdeven RH, et al. Characterization of the mammalian CORVET and HOPS complexes and their modular restructuring for endosome specificity. J Biol Chem. 2015;290(51):30280–30290. doi:https://doi.org/10.1074/jbc.M115.688440] [26463206]
- Saftig P. Lysosomes. Landes Bioscience/Eurekah. com; 2005.
- Xu H, Ren D. Lysosomal physiology. Annu Rev Physiol. 2015;77:57–80. doi:https://doi.org/10.1146/annurev-physiol-021014-071649] [25668017]
- Bourne Y, Henrissat B. Glycoside hydrolases and glycosyltransferases: families and functional modules. Curr Opin Struct Biol. 2001;11(5):593–600.
- King JV, Liang WG, Scherpelz KP, et al. Molecular basis of substrate recognition and degradation by human presequence protease. Structure. 2014;22(7):996–1007.
- Hanson SR, Best MD, Wong CH. Sulfatases: structure, mechanism, biological activity, inhibition, and synthetic utility. Angew Chem Int Ed Engl. 2004;43(43):5736–5763.
- Ding WX, Yin XM. Mitophagy: mechanisms, pathophysiological roles, and analysis. Biol Chem. 2012;393(7):547–564.
- Saito T, Sadoshima J. Molecular mechanisms of mitochondrial autophagy/mitophagy in the heart. Circ Res. 2015;116(8):1477–1490.
- Kausar S, Wang F, Cui H. The role of mitochondria in reactive oxygen species generation and its implications for neurodegenerative diseases. Cells. 2018;7(12):274.
- Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev. 2014;94(3):909–950. doi:https://doi.org/10.1152/physrev.00026.2013] [24987008]
- Chen Y, Dorn GW. PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria. Science. 2013;340(6131):471–475. ][https://doi.org/10.1126/science.1231031] [23620051]
- Lippai M, Low P. The role of the selective adaptor p62 and ubiquitin-like proteins in autophagy. Biomed Res Int. 2014;2014:832704.
- Vargas JN, Wang C, Bunker E, et al. Spatiotemporal control of ULK1 activation by NDP52 and TBK1 during selective autophagy. Mol Cell. 2019;74(2):347–362. doi:https://doi.org/10.1016/j.molcel.2019.02.010] [30853401]
- Jin SM, Youle RJ. PINK1- and Parkin-mediated mitophagy at a glance. J Cell Sci. 2012;125(Pt 4):795–799.
- Rakovic A, Ziegler J, Mårtensson CU, et al. PINK1-dependent mitophagy is driven by the UPS and can occur independently of LC3 conversion. Cell Death Differ. 2019;26(8):1428–1441. doi:https://doi.org/10.1038/s41418-018-0219-z]
- Zhang J, Ney PA. Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ. 2009;16(7):939–946.
- Chen Z, Siraj S, Liu L, et al. MARCH5-FUNDC1 axis fine-tunes hypoxia-induced mitophagy. Autophagy. 2017;13(7):1244–1245.
- Chakraborty J, Stockum S, Marchesan E, et al. USP14 inhibition corrects an in vivo model of impaired mitophagy. EMBO Mol Med. 2018;10(11):e9014., doi:https://doi.org/10.15252/emmm.201809014]
- McWilliams TG, Prescott AR, Montava-Garriga L, et al. Basal mitophagy occurs independently of PINK1 in mouse tissues of high metabolic demand. Cell Metab. 2018;27(2):439–449.
- von Stockum S, Marchesan E, Ziviani E. Mitochondrial quality control beyond PINK1/Parkin. Oncotarget. 2018;9(16):12550–12551. doi:https://doi.org/10.18632/oncotarget.23799] [29560088]
- Meco Curtis Me DA, Lauretti E, Praticό D. Autophagy dysfunction in Alzheimer’s disease: mechanistic insights and new therapeutic opportunities. Biol Psychiatry. 2019;87(9):797–807.
- Nixon RA. Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci. 2007;120(Pt 23):4081–4091.
- Orr ME, Oddo S. Autophagic/lysosomal dysfunction in Alzheimer's disease. Alzheimers Res Ther. 2013;5(5):53.
- Uddin MS, Mamun AA, Labu ZK, et al. Autophagic dysfunction in Alzheimer's disease: Cellular and molecular mechanistic approaches to halt Alzheimer's pathogenesis. J Cell Physiol. 2019;234(6):8094–8112.
- Mueed Z, Tandon P, Maurya SK, et al. Tau and mTOR: the hotspots for multifarious diseases in Alzheimer's development. Front Neurosci. 2018; 12:1017.
- Tramutola A, Triplett JC, Di Domenico F, et al. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD. J Neurochem. 2015;133(5):739–749.
- Spilman P, Podlutskaya N, Hart MJ, et al. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease . PloS One. 2010;5(4):e9979. doi:https://doi.org/10.1371/journal.pone.0009979] [20376313]
- Carvalho C, Santos MS, Oliveira CR, et al. Alzheimer's disease and type 2 diabetes-related alterations in brain mitochondria, autophagy and synaptic markers. Biochim Biophys Acta. 2015;1852(8):1665–1675.
- Gao F, Yang J, Wang D, et al. Mitophagy in Parkinson's disease: pathogenic and therapeutic implications. Front Neurol. 2017;8:527. doi:https://doi.org/10.3389/fneur.2017.00527] [29046661]
- Park JS, Davis RL, Sue CM. Mitochondrial dysfunction in Parkinson's disease: new mechanistic insights and therapeutic perspectives. Curr Neurol Neurosci Rep. 2018;18(5):21
- Wang B, Abraham N, Gao G, et al. Dysregulation of autophagy and mitochondrial function in Parkinson’s disease. Transl Neurodegener. 2016;5(1):1–9.
- Martin DD, Ladha S, Ehrnhoefer DE, et al. Autophagy in Huntington disease and huntingtin in autophagy. Trends Neurosci. 2015;38(1):26–35.
- Metzger S, Walter C, Riess O, et al. The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients. PLoS One. 2013;8(7):e68951.
- Ortega Z, Lucas JJ. Ubiquitin-proteasome system involvement in Huntington's disease. Front Mol Neurosci. 2014;7:77. doi:https://doi.org/10.3389/fnmol.2014.00077] [25324717]
- Schipper-Krom S, Juenemann K, Reits EA. The ubiquitin-proteasome system in Huntington’s disease: are proteasomes impaired, initiators of disease, or coming to the rescue. Biochem Res Int. 2012;2012:837015.
- Wang J, Wang CE, Orr A, et al. Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice. J Cell Biol. 2008;180(6):1177–1189.
- Sullivan PM, Zhou X, Hu F. Autophagy-lysosome dysfunction in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. In Lysosomes-associated diseases and methods to study their function. London: IntechOpen Limited;2017.
- Kim Y, Santos R, Gage FH, et al. Molecular mechanisms of bipolar disorder: progress made and future challenges. Front Cell Neurosci. 2017;11:30.
- Gulbins A, Schumacher F, Becker KA, et al. Antidepressants act by inducing autophagy controlled by sphingomyelin-ceramide. Mol Psychiatry. 2018;23(12):2324–2346.
- Merenlender-Wagner A, Malishkevich A, Shemer Z, et al. Autophagy has a key role in the pathophysiology of schizophrenia. Mol Psychiatry. 2015;20(1):126–132.
- Schneider JL, Miller AM, Woesner ME. Autophagy and schizophrenia: a closer look at how dysregulation of neuronal cell homeostasis influences the pathogenesis of schizophrenia. Einstein J Biol Med. 2016;31(1-2):34–39.
- Heinrich A, Nees F, Lourdusamy A, et al. From gene to brain to behavior: schizophrenia-associated variation in AMBRA1 alters impulsivity-related traits . Eur J Neurosci. 2013;38(6):2941–2945.
- La Barbera L, Vedele F, Nobili A, et al. Neurodevelopmental disorders: functional role of Ambra1 in autism and schizophrenia. Mol Neurobiol. 2019;56(10):6716–6724.
- McMahon J, Huang X, Yang J, et al. Impaired autophagy in neurons after disinhibition of mammalian target of rapamycin and its contribution to epileptogenesis. J Neurosci. 2012;32(45):15704–15714. doi:https://doi.org/10.1523/JNEUROSCI.2392-12.2012] [23136410]
- Faras H, Al Ateeqi N, Tidmarsh L. Autism spectrum disorders. Ann Saudi Med. 2010;30(4):295–300. doi:https://doi.org/10.4103/0256-4947.65261] [20622347]
- Goorden SM, van Woerden GM, van der Weerd L, et al. Cognitive deficits in Tsc1+/- mice in the absence of cerebral lesions and seizures. Ann Neurol. 2007;62(6):648–655. doi:https://doi.org/10.1002/ana.21317] [18067135]
- Crespi B, Read S, Ly A, et al. AMBRA1, autophagy, and the extreme male brain theory of autism. Autism Res Treat. 2019;2019:1968580. 10
- Dere E, Dahm L, Lu D, et al. Heterozygous ambra1 deficiency in mice: a genetic trait with autism-like behavior restricted to the female gender. Front Behav Neurosci. 2014;8:181.
- Mitjans M, Begemann M, Ju A, et al. Sexual dimorphism of AMBRA1-related autistic features in human and mouse. Transl Psychiatry. 2017;7(10):e124. doi:https://doi.org/10.1038/tp.2017.213] [28994820]
- Nobili A, Krashia P, Cordella A, et al. Ambra1 shapes hippocampal inhibition/excitation balance: role in neurodevelopmental disorders. Mol Neurobiol. 2018;55(10):7921–7940.
- Tang G, Gudsnuk K, Kuo SH, et al. Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits. Neuron. 2014;83(5):1131–1143.
- Ballou LM, Lin RZ. Rapamycin and mTOR kinase inhibitors. J Chem Biol. 2008;1(1-4):27–36. Nov
- Klümpen HJ, Beijnen JH, Gurney H, et al. Inhibitors of mTOR. Oncologist. 2010;15(12):1262–1269.
- Zullo AJ, Smith KL, Lee S. Mammalian target of Rapamycin inhibition and mycobacterial survival are uncoupled in murine macrophages. BMC Biochem. 2014;15(1):4.
- Law BY, Chan WK, Xu SW, et al. Natural small-molecule enhancers of autophagy induce autophagic cell death in apoptosis-defective cells. Sci Rep. 2014;4:5510. doi:https://doi.org/10.1038/srep05510] [24981420]
- Huang Y, Chen Y, Shaw AM, et al. Enhancing TFEB-mediated cellular degradation pathways by the mTORC1 inhibitor quercetin. Oxid Med Cell Longev. 2018;2018:5073420.
- Song JX, Sun YR, Peluso I, et al. A novel curcumin analog binds to and activates TFEB in vitro and in vivo independent of MTOR inhibition. Autophagy. 2016;12(8):1372–1389. doi:https://doi.org/10.1080/15548627.2016.1179404] [27172265]
- Tan S, Yu CY, Sim ZW, et al. Pomegranate activates TFEB to promote autophagy-lysosomal fitness and mitophagy. Sci Rep. 2019;9(1):727. doi:https://doi.org/10.1038/s41598-018-37400-1] [30679718]
- Martina JA, Puertollano R. Protein phosphatase 2A stimulates activation of TFEB and TFE3 transcription factors in response to oxidative stress. J Biol Chem. 2018;293(32):12525–12534.
- Wang C, Niederstrasser H, Douglas PM, et al. Small-molecule TFEB pathway agonists that ameliorate metabolic syndrome in mice and extend C. elegans lifespan. Nat Commun. 2017;8(1):2270.
- Yang Y, Chen S, Zhang Y, et al. Induction of autophagy by spermidine is neuroprotective via inhibition of caspase 3-mediated Beclin 1 cleavage. Cell Death Dis. 2017;8(4):e2738.
- Yu J, Lan L, Lewin SJ, et al. Identification of novel small molecule Beclin 1 mimetics activating autophagy. Oncotarget. 2017;8(31):51355–51369.
- Sebori R, Kuno A, Hosoda R, et al. Resveratrol decreases oxidative stress by restoring mitophagy and improves the pathophysiology of dystrophin-deficient mdx mice. Oxid Med Cell Longevity. 2018;2018:1–13.
- Yao ZQ, Zhang X, Zhen Y, He XY, et al. A novel small-molecule activator of Sirtuin-1 induces autophagic cell death/mitophagy as a potential therapeutic strategy in glioblastoma. Cell Death Dis. 2018;9(7):767.
- Jang SY, Kang HT, Hwang ES. Nicotinamide-induced mitophagy: event mediated by high NAD+/NADH ratio and SIRT1 protein activation . J Biol Chem. 2012;287(23):19304–19314. doi:https://doi.org/10.1074/jbc.M112.363747] [22493485]
- Vo MT, Smith BJ, Nicholas J, et al. Activation of NIX-mediated mitophagy and replication by an interferon regulatory factor homologue of human herpesvirus. bioRxiv. 2018;Jan:1:506113.